198 related articles for article (PubMed ID: 10641447)
1. Posttransfusion hepatitis B infection after revised screening for hepatitis B.
Arai M; Koshihara K; Takahashi Y; Fukutake K
Int J Hematol; 1999 Jan; 69(1):61. PubMed ID: 10641447
[No Abstract] [Full Text] [Related]
2. Transfusions of red blood cells from an occult hepatitis B virus carrier without apparent signs of transfusion-transmitted hepatitis B infection.
Furuta RA; Kondo Y; Saito T; Tomita M; Oka K; Kishimoto Y; Tani Y; Shibata T
Transfus Med; 2008 Dec; 18(6):379-81. PubMed ID: 19140823
[No Abstract] [Full Text] [Related]
3. Infectivity of HBV DNA positive donations identified in look-back studies in Hyogo-Prefecture, Japan.
Bouike Y; Imoto S; Mabuchi O; Kokubunji A; Kai S; Okada M; Taniguchi R; Momose S; Uchida S; Nishio H
Transfus Med; 2011 Apr; 21(2):107-15. PubMed ID: 21118317
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
[TBL] [Abstract][Full Text] [Related]
5. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening.
Allain JP
Vox Sang; 2007 Apr; 92(3):254-7. PubMed ID: 17348876
[TBL] [Abstract][Full Text] [Related]
6. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
7. [False-positive hepatitis serology after administration of immunoglobulins].
Strobel E; Schöniger M
Dtsch Med Wochenschr; 2006 Jun; 131(23):1325-7. PubMed ID: 16761202
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
9. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
[TBL] [Abstract][Full Text] [Related]
10. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B vaccination and the rate of seroconversion in high risk contacts.
Sengupta B; Sarkar A; De M; Lahiri P; Bhattacharya DK
J Indian Med Assoc; 1993 Nov; 91(11):281-2, 285. PubMed ID: 8138648
[TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
Panhotra BR; Bahrani A; Joshi CS; ul Hassan Z
J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
[No Abstract] [Full Text] [Related]
13. Occult hepatitis B virus infection.
Allain JP
Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
[TBL] [Abstract][Full Text] [Related]
14. Donor screening for hepatitis B virus infection in a cell and tissue bank.
Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
[TBL] [Abstract][Full Text] [Related]
15. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
16. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
17. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
18. Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen.
Walz A; Wirth S; Hucke J; Gerner P
J Infect Dis; 2009 Oct; 200(8):1227-31. PubMed ID: 19751152
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between circulating HBV-DNA, HBcAb titers and post-transfusional hepatitis B].
Bedarida G; Cambiè G; D'Agostino F
Riv Emoter Immunoematol; 1984; 31(1):88-100. PubMed ID: 6531624
[No Abstract] [Full Text] [Related]
20. [Hepatitis B and blood banks].
Bruguera M
Med Clin (Barc); 1992 Mar; 98(12):469-71. PubMed ID: 1573916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
